Clinical Trials Directory

Trials / Sponsors / Grupo Español de Investigación en Cáncer de Ovario

Grupo Español de Investigación en Cáncer de Ovario

Academic / Other · 14 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingClinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage
MMRd/MSI-H Stage II-III Endometrial Cancer
Phase 22025-10-01
UnknownDOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer
Endometrial Cancer
—2023-03-07
CompletedRetrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD
Ovarian Cancer
—2021-10-21
CompletedNiraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
—2020-09-30
CompletedAnalysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO St
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
—2020-07-29
Active Not RecruitingTSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiat
Cervical Cancer, Advanced Cancer
Phase 22019-06-28
CompletedPlatinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer
Recurrent Ovarian Carcinoma
Phase 32018-11-21
Active Not RecruitingPlatinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix
Carcinoma of the Cervix, Stage IVB
Phase 32018-09-25
CompletedOlaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma
Ovarian Cancer
Phase 22018-06-21
CompletedResistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin
Advanced Ovarian Cancer
Phase 22017-12-13
CompletedRetrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD
Ovarian Epithelial Cancer Recurrent
—2013-05-06
TerminatedNeoadjuvant Therapy in Advanced Ovarian Cancer With Avastin
Cancer, Ovarian
Phase 22013-05-06
CompletedClinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer
Platinum-resistant Advanced Ovarian Cancer
Phase 22010-12-01
CompletedCatumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease Rem
Ovarian Cancer
Phase 22010-06-01